healio.com
Media Bias Ratings
Does healio.com lean left or right?
Learn more about Media Bias Ratings.
Top healio.com News
Latest News Stories
MedicalIn patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology. In staged t…See the Story
Immediate complete revascularization is not inferior to staged procedure for treating multi-vessel disease
100% Center coverage: 2 sources
Coronavirus · New OrleansA therapeutic vs. prophylactic dose of anticoagulation therapy did not significantly improve outcomes for noncritically ill patients hospitalized with COVID-19. The FREEDOM COVID trial ultimately did not meet its primary endpoint, Valentin Fuster, MD, PhD, said during a late-breaking clinical trials presentation.See the Story
Therapeutic-dose anticoagulation may improve COVID-19 outcomes for noncritical inpatients – Healio
Medical · New OrleansPatients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs, who were treated with the novel first-in-class medication sotatercept on top of existing therapy experienced significant improvements in walking distance via a six-minute walking test—the study's primary endpoint and a validated surrogate for functional improvement and reduced symptom burden.See the Story
Addition of sotatercept to existing therapy shows promise for the treatment of pulmonary arterial hypertension
100% Center coverage: 1 sources
Medical · New OrleansBempedoic acid (Nexletol,Esperion) lowered LDL cholesterol by 21% in the study. The drug was also well-tolerated in the mixed population of primary and secondary prevention patients unable or unwilling to take statins. "These findings establish bempedoic acid as an effective approach to reduce major cardiovascular events in statin-intolerant patients," the study chair concluded.See the Story
